Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ivan Bilić"'
Autor:
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
Publikováno v:
Pharmacogenomics. 24:93-106
Fluoropyrimidines (FPs) are antineoplastic drugs widely used in the treatment of various solid tumors. Nearly 30% of patients treated with FP chemotherapy experience severe FP-related toxicity, and in some cases, toxicity can be fatal. Patients with
Publikováno v:
Advances in Service and Industrial Robotics ISBN: 9783031326059
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eea45db7dcd85dcacaa1b1c0140121dd
https://doi.org/10.1007/978-3-031-32606-6_48
https://doi.org/10.1007/978-3-031-32606-6_48
Autor:
Nada Božina, Livija Šimičević, Lucija Lešnjaković, Lana Ganoci, Vladimir Trkulja, Ivan Bilić, Stjepko Pleština
Aims: Cancer patients with reduced dihydropyrimidine dehydrogenase (DPD) activity are at increased risk of severe fluoropyrimidine (FP)- related adverse events (AE). Guidelines recommend FP dosing adjusted to genotype-predicted DPD activity based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7438985ccb91853fa76427bd2844cf28
https://www.bib.irb.hr/1189878
https://www.bib.irb.hr/1189878
Autor:
Nada, Božina, Ivan, Bilić, Lana, Ganoci, Livija, Šimičević, Stjepko, Pleština, Lucija, Lešnjaković, Vladimir, Trkulja
Publikováno v:
British journal of clinical pharmacologyREFERENCES. 88(5)
Cancer patients with reduced dihydropyrimidine dehydrogenase (DPD) activity are at increased risk of severe fluoropyrimidine (FP)-related adverse events (AE). Guidelines recommend FP dosing adjusted to genotype-predicted DPD activity based on four DP
Autor:
Lucija Lešnjaković, Vladimir Trkulja, Ivan Bilić, Stjepko Pleština, Livija Šimičević, Lana Ganoci, Nada Bozina
Aim. Cancer patients with reduced dihydropyrimidine dehydrogenase (DPD) activity are at increased risk of severe fluoropyrimidine (FP)-related adverse events (AE). Guidelines recommend FP dosing adjusted to genotype-predicted DPD activity based on fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f0049161ca6b8c61322f71d0e021132
https://doi.org/10.22541/au.163256318.81541809/v1
https://doi.org/10.22541/au.163256318.81541809/v1
Autor:
Ziyuan Wu, Ole Bæk, Tik Muk, Lin Yang, René Liang Shen, Bagirath Gangadharan, Ivan Bilic, Dennis Sandris Nielsen, Per Torp Sangild, Duc Ninh Nguyen
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 179, Iss , Pp 117391- (2024)
Necrotizing enterocolitis (NEC) is a microbiota- and feeding-related gut inflammatory disease in preterm infants. The standard of care (SOC) treatment for suspected NEC is antibiotic treatment and reduced enteral feeding, but how SOC treatment mitiga
Externí odkaz:
https://doaj.org/article/f5f15af4e8754dd6bf0c264fabc0ce5f
Metastatic involvement of the breast is far less common than primary breast carcinoma, comprising 0.5%-6.6% of all breast malignancies. Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with higher incidence among men, particularly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::372b4c7694ef9a9065f858a2e07662cb
https://doi.org/10.1111/tbj.13898
https://doi.org/10.1111/tbj.13898
Publikováno v:
Archives of Industrial Hygiene and Toxicology. 67:1-8
Interindividual variability in drug metabolism is an important cause of adverse drug reactions and variability in drug efficiency. Polymorphisms of cytochrome P450 (CYPs) genes have a significant effect on drug metabolism and toxicity. This review br
Autor:
Daška Štulhofer Buzina, Ivana Martinac, Danijela Ledić Drvar, Romana Čeović, Ivan Bilić, Branka Marinović
Publikováno v:
Acta Dermatovenerologica Croatica
Volume 24
Issue 1
Volume 24
Issue 1
Dear Editor, Inhibition of the epidermal growth factor receptor (EGFR) is a new strategy in treatment of a variety of solid tumors, such as colorectal carcinoma, non-small cell lung cancer, squamous cell carcinoma of the head and neck, and pancreatic
Publikováno v:
Arhiv za higijenu rada i toksikologiju
Volume 67
Issue 1
Volume 67
Issue 1
Interindividual variability in drug metabolism is an important cause of adverse drug reactions and variability in drug efficiency. Polymorphisms of cytochrome P450 (CYPs) genes have a significant effect on drug metabolism and toxicity. This review br